ShangBay Capital LLC
Venture capitalPalo Alto · Seed–Series A · 13 people tracked
Investment thesis
ShangBay Capital focuses on backing founders who build disruptive companies targeting large, unmet clinical needs through novel approaches. The firm cultivates relationships with investors, entrepreneurs, KOLs, strategics, and industry innovators, and leverages a leadership team with a combined 100+ years of experience and deep ties to strategics and innovators in disruptive technologies. Its aim is to help founders address significant market needs while generating favorable returns.
Source: firm website, verified Aug 25, 2026.
Team · 13 people
from the firm's website & public directories
What they invest in
from 49 of 72 portfolio companiesHealthtech ×36Medical Devices ×32Biotech ×23Digital Health ×8Hardware ×7Deep Tech ×6AI & Machine Learning ×5Robotics ×3
HQs:United States×37China×1Germany×1
Who they back
founder profiles across 28 portfolio companiesFounding team size:solo founder×142 founders×93 founders×44+ founders×1
Accelerator rootsportfolio companies that came through a program
Investments · 72 tracked
founders shown can be your intro pathBy year:2026 · 32025 · 22024 · 32023 · 32020 · 22019 · 12016 · 12014 · 116 dated
Ceribell is a medical technology company that develops products for detecting and monitoring seizures, including EEG-based diagnostic systems.
AI & Machine LearningDigital HealthHealthtechMedical DevicesSunnyvale, US
Josef Parvizi(Director)Xingjuan Chao(Executive Officer, Director)Xingjuan (Jane) Chao(President, CEO, Co-Founder & Director)Scott Blumberg(Executive Officer)Joseph Taylor(Director)Raymond Woo(Executive Officer)
Co-investorsLongitude CapitalRA CapitalRed Tree Venture
BiotechShelton, US
Josef Schoell(Executive Officer)Jeffrey L. Ives(Director)Joseph W. Stauffer(Executive Officer)Derek Chalmers(Executive Officer, Director)Michael E. Lewis(Executive Officer)Martin Vogelbaum(Director)
Luminopia is an FDA-cleared binocular therapy for amblyopia in children aged 4-12 that uses a VR headset to stream the child's favorite TV shows as treatment, replacing traditional eye patches.
BiotechDigital HealthHealthtechMedical DevicesAspen, US
DEAN A. TRAVERS(Executive Officer, Director)SCOTT XIAO(Executive Officer, Director)Scott Xiao(Co-Founder & CEO)Dean Travers(Co-Founder)Brion Raymond(CBO)Drew Mowery(VP of Commercial Strategy)
Co-investorsBantam GroupGood FriendsNXT VenturesSony Ventures CorporationUS Venture PartnersU.S. Venture Partners
Petal is developing an incisionless surgery platform using Millisecond Pulse Histotripsy, a form of focused therapeutic ultrasound that breaks down targeted diseased tissue without incisions, heat, or trauma.
BiotechDeep TechHealthtechMedical DevicesRedwood City, US
Prash Chopra(Founding CEO & Director)Bowen Jiang(Co-founder)Nicholas Theodore(Co-founder & Director)Prashant Chopra(Executive Officer, Director, Promoter)
BoardFrederic Moll(Director)Rony Abovitz(Co-founding Advisor)
Co-investorsTSVCDolma VenturesSonder Futures
Petal Surgical develops an incisionless surgery platform using Millisecond Pulse Histotripsy, a form of focused therapeutic ultrasound that breaks down targeted tissue via "Acoustic Liquefaction" without cutting, heat, or trauma.
Deep TechHealthtechMedical Devices
Bowen Jiang(Co-founder)Nicholas Theodore(Co-founder & Director)Prash Chopra(Founding CEO & Director)Frederic H. Moll(Director)Rony Abovitz(Co-founding Advisor)
Co-investorsTSVCHike VenturesK50 Ventures
Abcuro develops therapies that target highly cytotoxic T cells for autoimmune diseases, including its lead candidate ulviprubart for inclusion body myositis.
BiotechHealthtechNewton, US
Steven A. Greenberg(Chief Scientific Advisor & Co-Founder)Steven A. Greenberg, MD(Chief Scientific Advisor & Co-Founder)John Alexander Martin(Executive Officer, Director)Stefano Gulla(Executive Officer)Evan Thompson(Executive Officer)David de Graaf(Executive Officer, Director)
Co-investorsBain Capital Life SciencesNew Enterprise Associates (NEA)RA CapitalSamsara BioCapitalSanofi VenturesMass General Brigham Ventures+8 more
Co-investorsEFung Capital
BiotechMenlo Park, US
Dongliang Ge(Executive Officer, Director)Xin Guo(Director)Bo Zhang(Executive Officer, Director)
BoardWilliam Dai(Director)in
Co-investorsAmino Capital
Through-the-endoscope vapor ablation platform for treating metabolic disease and type 2 diabetes via transoral duodenal ablation
BiotechSanta Ana, US
MICHAEL MADDEN(Executive Officer)SEAN McWEENEY(Executive Officer)HAZIM ANSARI(Executive Officer)Lloyd Mencinger(Executive Officer, Director)VIRENDER SHARMA(Executive Officer, Director)
BoardGREG BARRETT(Director)
Co-investorsRelevance Ventures
ARANZ Medical develops Silhouette, a wound care workflow platform for clinicians that tracks, charts, and reports on wound healing while connecting to clinical, billing, and supply management systems.
Digital HealthHealthtechMedical Devices
Co-investors7 Gate VenturesSv Tech Ventures, Inc.
BiotechCampbell, US
Henry Chen(Director)Claudio Argento(Director)Mariam Maghribi(Executive Officer, Director)Amr Salahieh(Director)Casey Gordon(Director)
Co-investorsRising Tide
Avation Medical manufactures the Vivally System, an FDA-cleared wearable device that uses transcutaneous tibial nerve stimulation to treat overactive bladder and urge urinary incontinence in at-home 30-minute sessions.
Digital HealthHealthtechMedical DevicesValencia, US
Jill Schiaparelli(Executive Officer, Director)Kevin Wasserstein(Director)
BoardThomas Shehab, MD(Director)
Co-investorsAngelini VenturesArboretum VenturesAvestria Ventures
Berkeley Lights (now Bruker Cellular Analysis) develops the Beacon optofluidic system for single-cell functional analysis, enabling researchers to profile live single cells to discover therapeutic antibodies, interrogate T cells, identify cell therapies, and accelerate cell line development.
BiotechDeep TechHardwareEmeryville, US
Ming Wu(Director)Igor Khandros(Executive Officer, Director)Lip-Bu Tan Tan(Director)William Davidow(Director)James Rothman(Director)John Gunn(Director)
Co-investorsCelesta CapitalCelesta CapitalCota CapitalKhosla VenturesOpen Field CapitalWalden Catalyst+1 more
Chimera develops engineered cell therapies for cancer that produce therapeutic proteins only upon encountering tumor cells, using natural biological control mechanisms to improve safety and efficacy.
BiotechHealthtech
CloudMedx uses machine learning, natural language understanding, and healthcare-specific fine-tuned LLMs to analyze healthcare data and generate clinical, operational, and financial insights.
AI & Machine LearningDigital HealthHealthtechPalo Alto, US
Tashfeen Suleman(Executive Officer)Sahar Arshad(Director)
Co-investorsDFJ DragonFundFundersClub
Contraline develops new contraceptive and reproductive health technologies, with a focus on male contraception.
BiotechDigital HealthMedical DevicesCharlottesville, US
Kevin S Eisenfrats(Executive Officer, Director, Promoter)Kevin Eisenfrats(Co-Founder and CEO)John Herr(Co-Founder)
BoardIris Van Alderwerelt van Rosenburgh(Director)Gurdane Bhutani(Director)inMartin J Emerson(Director)
Co-investorsBiotechnology Value FundMBX CapitalAllied Venture PartnersAmboy Street VenturesAurum Venture PartnersBeni Venture Capital+14 more
CURE operates a booking platform that connects pharmacies with delivery service partners to generate online orders.
B2B MarketplacesHealthtechSaaSBerlin, DE
Manuel Aberle(Founder)
Co-investorsAbstract VenturesArtis VenturesJ12 VenturesAccompliceCatalyst Health VenturesCosmic Venture Partners+15 more
Devoro Medical developed the WOLF Thrombectomy Platform, a non-console, lytic-free medical device that uses finger-like prongs to capture and remove blood clots (thrombi) from the arterial and venous systems.
HardwareHealthtechMedical DevicesFremont, US
BoardErik Engelson(Director)Michael Wallace(Executive Officer, Director)Skott Greenhalgh(Director)
Co-investorsAPERTURE Venture PartnersNorwest Venture Partners
EpimAb Biotherapeutics develops bispecific antibody drugs for immuno-oncology and other high-need therapeutic areas using its proprietary FIT-Ig platform, with a pipeline of clinical programs (EMB-01, EMB-06, EMB-07) and preclinical candidates.
BiotechHealthtechShanghai, CN
Co-investorsDecheng CapitalTCG Labs3E Bioventures CapitalSherpa Healthcare Partners
FemDx Medsystems is a medical device company developing minimally invasive technologies for diagnosing and treating gynecological conditions, with a focus on reproductive health and gynecological cancers.
FemTechHealthtechMedical Devices
Co-investorsPortfolia
Flare Therapeutics is a drug discovery company developing small molecule therapies that target transcription factors to restore transcriptional control disrupted by cancer.
BiotechHealthtech
Co-investorsNextech InvestPfizer Venture InvestmentsAgent Capital
Fluid Biomed develops the ReSolv stent, a hybrid polymer-metal, self-expanding flow-diverting stent designed to treat brain aneurysms and reduce the risk of rupture and stroke.
BiotechHealthtechMedical Devices
Co-investorsAccelerate FundLifeArc VenturesThin Air LabsUCeed Funds
IgGenix is a clinical-stage biotechnology company focused on antibody discovery and development for allergies and immunological diseases.
AI & Machine LearningBiotechHealthtechSouth San Francisco, US
Kari Nadeau(Scientific Co-Founder)
Co-investorsKhosla VenturesAllerfund Ventures, LlcFemHealth VenturesGlobal BrainMedical Incubator Japan K.K.SBI Investment
Immune Onc is a biotechnology company developing medicines to treat patients with hard-to-treat cancers and autoimmune diseases, with expertise in translational medicine and clinical development.
BiotechMedical DevicesPalo Alto, US
Xiaoling Charlene Liao(Executive Officer, Director)
BoardGuo-Liang Yu(Director)Liqun Luo(Director)
Co-investorsNorthern Light Venture CapitalVivo Capital
Inquis Medical develops the AVENTUS Thrombectomy System, a catheter-based device for removing blood clots and reinfusing blood to treat pulmonary embolism and venous thromboembolism.
HardwareHealthtechMedical DevicesMenlo Park, US
Laplace Interventional develops a transcatheter tricuspid valve replacement system that delivers a prosthetic valve percutaneously, avoiding open-heart surgery for patients with tricuspid regurgitation.
HealthtechMedical DevicesPlymouth, US
Ramji Iyer(Executive Officer, Director)
BoardJenny H. Barba(Director)Todd Mortier(Director)Colin Morrison(Director)
Co-investorsAphelion Capitalgener8tor
Lucira Health manufactures portable diagnostic devices that connect to smartphones to test bodily fluids for infectious diseases, enabling rapid results outside of clinical settings.
BiotechHealthtechMedical DevicesEmeryville, US
Debkishore Mitra(Founder)inJohn R. Waldeisen(Director)
BoardErik T. Engelson(Executive Officer, Director)Justin Butler(Director)Tuff Yen(Director)Steve Tablak(Director)
Co-investors11.2 CapitalForesite CapitalY CombinatorOS Fund
Magnetic Insight develops magnetic particle imaging technology that uses non-radioactive tracers as an alternative to conventional radioactive tracers used in nuclear medicine scans.
Deep TechHealthtechMedical Devices
Co-investors5AM VenturesInnolinks Ventures
Mediartx develops novel therapies for patients with fibrotic diseases.
BiotechMedical DevicesBoston, US
Rahul Ballal, PhD(CEO)Paul Yaworsky, PhD(CSO)inRahul Ballal(Executive Officer, Director)Brian Hubbard(Director)Stacey Brenner(Executive Officer)David de Graaf(Director)
Co-investorsLongwood FundMission BiocapitalNovartis Venture FundOno Venture Investment, Inc.Pfizer Venture InvestmentsSofinnova Partners+2 more
Neptune Medical is a medical device company developing GI endoscopy products based on its Dynamic Rigidization technology, including the FDA-cleared Pathfinder endoscope and the Triton robotic endoscopy system for colon navigation.
HealthtechMedical DevicesRoboticsSilicon Valley, US
Alex Tilson(Founder & CEO)in
Co-investorsSonder CapitalInCube VenturesMighty Capital
Nervonik develops peripheral nerve stimulation (PNS) systems designed for high-motion, dynamic activity, using a patented technology that adds biosensing and objective feedback to neuromodulation.
HardwareHealthtechMedical Devices
Co-investorsFoothill VenturesLumira VenturesUS Venture PartnersAmzak Health
HealthtechSan Francisco, US
Amit Vohra(Executive Officer, Director)Abhita Batra(Executive Officer, Director)Shibu Gangadharan(Executive Officer)
BoardKrishna R. Bhupal(Director)Rahul Talwar(Director)
Co-investorsFrontier Path VC
NeuroVasc Technologies develops catheter-based medical devices designed to treat stroke and other neurological conditions.
Deep TechHealthtechMedical DevicesCalifornia, US
JIANLU MA(Executive Officer, Director)
BoardLU GANG(Director)WILLIAM DAI(Director)inJEFF PETERS(Director)DAVE FERRERA(Director)
Co-investorsSv Tech Ventures, Inc.
Noah Medical develops the Galaxy System, a robotic bronchoscopy platform that integrates advanced imaging, precision targeting, and adaptive workflow for real-time lesion localization and lung diagnostics.
HealthtechMedical DevicesRobotics
Co-investors1955 CapitalChina Growth CapitalLYFE CapitalProsperity7 Ventures
OrthoFX makes AirFlex clear dental aligners built with a patented HyperElastic polymer that delivers lower, sustained force for orthodontic treatment.
ConsumerHealthtechMedical DevicesFremont, US
Nichole Garcia(Founder)Ren Menon(Founder)inHenry Chan(Founder)in
Co-investorsXRCSignalFireUnusual Ventures
Petal offers credit card products aimed at helping people access credit, including those new to credit or with past credit issues, by using their savings and spending data to assess creditworthiness beyond a traditional credit score.
ConsumerFintechOxford, US
David Michael Melnick Taffet(Executive Officer)
Co-investorsAfore CapitalEvolution VC PartnersFairhaven Capital PartnersNelstone VenturesNew Ground VenturesRosecliff Ventures+5 more
Pykus Therapeutics is a clinical-stage medical technology company developing biodegradable polymers for vitreoretinal surgery.
BiotechHealthtechMedical DevicesCambridge, US
James (Tony) Stefater(Founder)inJames A. Stefater(Executive Officer)Michael Singer(Director)Richel Liu(Director)Thomas P. Stryjewski(Director)Sameer Sabir(Director)
Co-investorsBeacon Angels
Radiaction develops radiation-shielding technology for medical teams performing fluoroscopy-guided procedures, mounting a dynamic scatter-radiation barrier directly onto the fluoroscopy system rather than on personnel.
HardwareHealthtechMedical Devices
SetPoint Medical develops an FDA-approved implantable neurostimulation device that stimulates the vagus nerve to reduce inflammation, offering a device-based treatment for adults with moderate-to-severe rheumatoid arthritis who have not responded to biologic or targeted synthetic drugs.
BiotechHealthtechMedical DevicesValencia, US
Murthy Simhambhatla(CEO)David Chernoff(Chief Medical Officer (MD))Yaakov Levine(PhD)Rohan Seth(Executive Officer)
BoardBlake Wu(Director)Juan-Pablo Mas(Director)
Co-investorsAlly Bridge GroupNew Enterprise Associates (NEA)Norwest Venture PartnersTopspin PartnersCatalio Capital Management, LPCitta Capital+4 more
Developing SKY-0515 for Huntington's Disease; running the global pivotal FALCON-HD clinical trial.
Co-investorsAgent CapitalGood Growth Capital
Solenic Medical is a medical company; this page is an investor contact form and does not describe the company's products or technology in detail.
Medical DevicesCollege Station, US
James Y Lancaster(Executive Officer, Director)
BoardJohn Hodock(Director)Robert Calvin Goforth(Director)
Co-investorsSugati VenturesJohnson & Johnson Innovation – JJDC
Sonovascular is developing an interventional treatment for venous thromboembolism (VTE) that uses microbubble-mediated cavitation, delivered as a cath lab-based procedure without requiring ICU treatment.
BiotechHealthtechMedical DevicesChapel Hill, US
Daniel Estay(Executive Officer, Director)inWilliam N. Starling(Director)
Co-investorsBand of AngelsWolfpack Investor Network
SoundHealth develops FDA 510(k) cleared, drug-free medical devices that use acoustic resonance therapy via forehead bone conduction to treat nasal congestion and improve sleep.
AI & Machine LearningDigital HealthMedical Devices
Co-investorsG Vision CapitalJ4 VenturesMoai CapitalTau Ventures
Sporos Bioventures is a private biotechnology company that uses a portfolio approach to drug development in oncology, holding equity stakes in biopharma entities such as Tvardi Therapeutics and Sporos BioDiscovery.
BiotechHealthtechHouston, US
Telesair develops medical devices focused on patient care, with work spanning strategy, design, engineering, and quality assurance.
AI & Machine LearningHardwareHealthtechMedical DevicesIrvine, US
Don Lin(Co-founder & CEO)Ken Wang(Executive Officer, Director)Dongping Lin(Executive Officer, Director)Matt Margolies(Executive Officer, Director)Jing Zhang(Director)Bo Li(Director)
BiotechMenlo Park, US
Dongxu Sun(Executive Officer, Director)Ke Hong(Executive Officer, Director)
Venova Medical develops the Velocity percutaneous arteriovenous fistula system, a minimally invasive medical device designed to create vascular access for hemodialysis patients more efficiently than traditional surgical methods.
HealthtechMedical DevicesLos Gatos, US
Erik van der Burg(Executive Officer, Director)in
BoardMichael Wallace(Director)inDarshana Zaveri(Director)inShant Vartanian(Director)in
Co-investorsAphelion Capital
Window Therapeutics is a biotechnology company developing therapeutics for cancer and other life-threatening diseases, based on its bottle-brush-analogue-macromonomer (BAM) technology.
BiotechDeep TechHealthtechBoston, US
James Lu(Director)Jeremiah Johnson(Founder (based on BAM technology from his MIT lab))Lusong Luo(Director)Chih-Kao Hu(Executive Officer, Director)
BoardKenneth Anderson(Director)Kenneth C. Anderson(Professor, Researcher and Clinician, Harvard Medical School & DFCI)
YorLabs develops an intracardiac echocardiography (ICE) ultrasound imaging system aimed at interventional cardiology and electrophysiology procedures.
Digital HealthHardwareMedical DevicesBeaverton, US
Clark Brooks(Founder)Sunit Rikhi(Founder)
ZAP Surgical develops the ZAP-X Gyroscopic Radiosurgery platform, a self-shielded surgical robotics system for non-invasive cranial stereotactic radiosurgery (SRS) that uses linear accelerator technology instead of radioactive sources.
HealthtechMedical DevicesRobotics
John R. Adler, Jr.(Founder)
Zenflow develops medical devices for treating benign prostatic hyperplasia (BPH) in men, founded from the Stanford Byers Center for Biodesign with a team experienced in medical device development and FDA regulation.
HealthtechMedical DevicesSan Francisco, US
Shreya Mehta(Founder/CTO)inNick Damiano(Executive Officer, Director)John Beck(Executive Officer)
BoardBryan Kim(Director)Robert Weisskoff(Director)inBlayne Roeder(Director)
Co-investorsAstiaF-Prime CapitalY CombinatorDorm RoomGolden SeedsMedical Technology Venture Partners
Exits · 2
IPOs and acquisitions across the tracked portfolioCeribellNASDAQ: CBLLTvardi TherapeuticsNASDAQ: TVRD
Portfolio news
latest coverage across their companiesCure · beautyindependent.com · Aug 20, 2026
Abcuro · clinicaltrialsarena.com · Aug 19, 2026
SoundHealth · sleepreviewmag.com · Aug 19, 2026
Contraline · fiercebiotech.com · Aug 12, 2026
Petal · whalesbook.com · Aug 5, 2026
Flare Therapeutics · allsci.com · Jul 1, 2026
Solenic Medical · beckersspine.com · Jun 23, 2026
Frequently asked questions
- How many investments has ShangBay Capital LLC made?
- ShangBay Capital LLC has 66 tracked investments, 1 of which have exited via acquisition or IPO, including 3 dated in the last 24 months.
- What stage does ShangBay Capital LLC invest at?
- ShangBay Capital LLC invests at the Seed, Series A stages.
- What sectors does ShangBay Capital LLC focus on?
- ShangBay Capital LLC focuses on Biotech, Healthtech, Medical Devices.
- Where is ShangBay Capital LLC located?
- ShangBay Capital LLC is headquartered in Palo Alto, US.
- Does ShangBay Capital LLC lead rounds?
- ShangBay Capital LLC has led 3 of the 5 rounds where its role is on record.
- Who does ShangBay Capital LLC co-invest with?
- ShangBay Capital LLC most often shares deals with RA Capital, Lumira Ventures, New Enterprise Associates (NEA), among 95 tracked co-investors.
Co-investors · 7
Norwest Venture Partners is an investment firm whose growth equity team backs private, profitable, fast-growing companies, providing capital and hands-on support through its 'invited guest' approach.
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
Sony Innovation Fund is the corporate venture capital arm operated by Sony Ventures Corporation, investing in technology and entertainment startups worldwide.
Action Potential Venture Capital is a corporate venture fund backed by GSK that invests in peripheral neuromodulation medical devices and bioelectronics technologies.
Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.
Morgenthaler is a venture capital and private equity firm that has focused on building valuable companies for over 40 years.
Amplitude Venture Capital is a Canadian venture firm that creates, builds, and grows precision medicine companies aimed at improving patient outcomes.
Firms observed investing alongside ShangBay Capital LLC, from public investor directories. Shared companies are the overlap with ShangBay Capital LLC's recorded portfolio.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.